
    
      The aim of the intervention is to analyse the effect of a probiotic supplement in a
      dose-responsive set up on symptoms of irritable bowel syndrome (IBS). Fulfillment of Rome III
      criteria will be used as inclusion criterion. Subjective assessment of bowel symptoms,
      IBS-related quality of life and adequate relief will be assessed as outcome measures.
    
  